Discover
RXRX
Recursion Pharmaceuticals, Inc.
3.67
7 x 3.64
2 x 4.67
bid
ask
+
0.00
0.00%
5 @ 06:20 AM
3.63 -0.04 (1.09%)
| Ytd | -10.27% | |
| 1y | -29.56% |
3.61
day range
4.04
2.77
52 week range
7.18
| Open | 3.66 | Prev Close | 3.67 | Low | 3.61 | High | 4.04 | Mkt Cap | 1.95B |
| Vol | 35.56M | Avg Vol | 16.93M | EPS | -1.16 | P/E | N/A | Forward P/E | -4.18 |
| Beta | 1.00 | Short Ratio | 8.63 | Inst. Own | 68.78% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 3.32 | 200-d Avg | 4.10 | 1yr Est | 6.64 |
| Income Statement | |||
| Total Revenue | 6.47M | ||
| Revenues (USD) | 6.47M | ||
| Cost of Revenue | 12.49M | ||
| Gross Profit | -6.02M | ||
| Operating Expenses | 122.49M | ||
| Research and Development Expense | 87.90M | ||
| Selling, General and Administrative Expense | 34.59M | ||
| Operating Income | -128.50M | ||
| Income Tax Expense | -4.60M | ||
| Net Income | -117.50M | ||
| Net Income Common Stock | -117.50M | ||
| Net Income Common Stock (USD) | -117.50M | ||
| Consolidated Income | -117.50M | ||
| Earnings per Basic Share | -0.22 | ||
| Earnings per Basic Share (USD) | -0.22 | ||
| Earnings per Diluted Share | -0.22 | ||
| Earning Before Interest & Taxes (EBIT) | -122.11M | ||
| Earning Before Interest & Taxes (USD) | -122.11M | ||
| Weighted Average Shares | 529.30M | ||
| Weighted Average Shares Diluted | 529.30M | ||
| Balance Sheet | |||
| Cash and Equivalents | 659.98M | ||
| Cash and Equivalents (USD) | 659.98M | ||
| Investments | 5.20M | ||
| Investments Non-Current | 5.20M | ||
| Trade and Non-Trade Receivables | 13.59M | ||
| Current Assets | 709.56M | ||
| Property, Plant & Equipment Net | 157.32M | ||
| Total Assets | 1.34B | ||
| Debt Current | 22.35M | ||
| Total Debt | 72.38M | ||
| Current Liabilities | 129.70M | ||
| Debt Non-Current | 50.02M | ||
| Total Liabilities | 314.75M | ||
| Accumulated Retained Earnings (Deficit) | -2.19B | ||
| Accumulated Other Comprehensive Income | 26.66M | ||
| Shareholders Equity | 1.02B | ||
| Shareholders Equity (USD) | 1.02B | ||
| Assets Non-Current | 629.97M | ||
| Total Debt (USD) | 72.38M | ||
| Deferred Revenue | 147.52M | ||
| Goodwill and Intangible Assets | 454.24M | ||
| Liabilities Non-Current | 185.05M | ||
| Trade and Non-Trade Payables | 20.35M | ||
| Tax Assets | 957.00K | ||
| Tax Liabilities | 18.28M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 24.92M | ||
| Net Cash Flow from Financing | -3.47M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -88.74M | ||
| Capital Expenditure | -258.00K | ||
| Issuance (Purchase) of Equity Shares | -1.26M | ||
| Issuance (Repayment) of Debt Securities | -2.21M | ||
| Net Cash Flow from Investing | -338.00K | ||
| Net Cash Flow from Operations | -81.10M | ||
| Effect of Exchange Rate Changes on Cash | -3.83M | ||
| Share Based Compensation | 22.22M | ||